Search - tctmd.com

Displaying 521 - 540 of 799

Sort: Relevancy | Date

News Daily News

Which ASCVD Patients Will Benefit Most From Rivaroxaban Plus Aspirin? Some Clues

Todd Neale

June 26, 2019

News Conference News EAS 2019

Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role

Michael O'Riordan

June 07, 2019

News Daily News

Higher Risk of Intracranial Hemorrhage With Aspirin in Primary Prevention

Michael O'Riordan

May 20, 2019

News Conference News HRS 2019

Even in the DOAC Era, Women Less Likely Than Men to Receive Anticoagulation for A-fib

Todd Neale

May 17, 2019

News Daily News

Risk Prediction Tool Shows Promise for Detecting Heart Failure Earlier

L.A. McKeown

May 13, 2019

News Daily News

FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors

Michael O'Riordan

May 08, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2019

Shelley Wood

May 01, 2019

News Daily News

Analysis Supports Aiming for Lower BP in Patients With Diabetes, Hypertension

Todd Neale

April 29, 2019

News Daily News

Omega-3 PUFAs Offset Adverse CV Effects of Air Pollution in Small, Chinese Study

Michael O'Riordan

April 24, 2019

News Daily News

Will Less Aggressive Lp(a) Targets Do the Trick? Time and Clinical Trials Will Tell

Yael L. Maxwell

April 24, 2019

News Daily News

No Need for Niacin? Meta-analysis Argues the End Is Nigh

Yael L. Maxwell

April 22, 2019

News Daily News

Zero CAC Reliably Excludes CAD Among Stable, Symptomatic Patients, but Experts Debate Its Need

Yael L. Maxwell

April 18, 2019

News Daily News

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

L.A. McKeown

April 03, 2019

News Conference News ACC 2019

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

Yael L. Maxwell

March 27, 2019

News Conference News ACC 2019

Amlodipine the Key Component in Dual BP Therapy in Sub-Saharan Africa: CREOLE

Caitlin E. Cox

March 25, 2019

News Conference News ACC 2019

REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events

Yael L. Maxwell

March 22, 2019

News Conference News ACC 2019

Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom

Michael O'Riordan

March 20, 2019

News Conference News ACC 2019

New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead

Michael O'Riordan

March 17, 2019

News Daily News

High Rates of Unnecessary Aspirin Use in A-fib/VTE Patients on Warfarin

Shelley Wood

March 08, 2019

News Daily News

Rising Inflammatory Tides: Increasing CRP Levels After ACS Tied to Greater CVD Risks

Michael O'Riordan

March 08, 2019

Advertisement

Which ASCVD Patients Will Benefit Most From Rivaroxaban Plus Aspirin? Some Clues

Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role

Higher Risk of Intracranial Hemorrhage With Aspirin in Primary Prevention

Even in the DOAC Era, Women Less Likely Than Men to Receive Anticoagulation for A-fib

Risk Prediction Tool Shows Promise for Detecting Heart Failure Earlier

FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors

TCTMD’s Top 10 Most Popular Stories for April 2019

Analysis Supports Aiming for Lower BP in Patients With Diabetes, Hypertension

Omega-3 PUFAs Offset Adverse CV Effects of Air Pollution in Small, Chinese Study

Will Less Aggressive Lp(a) Targets Do the Trick? Time and Clinical Trials Will Tell

No Need for Niacin? Meta-analysis Argues the End Is Nigh

Zero CAC Reliably Excludes CAD Among Stable, Symptomatic Patients, but Experts Debate Its Need

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

Amlodipine the Key Component in Dual BP Therapy in Sub-Saharan Africa: CREOLE

REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events

Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom

New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead

High Rates of Unnecessary Aspirin Use in A-fib/VTE Patients on Warfarin

Rising Inflammatory Tides: Increasing CRP Levels After ACS Tied to Greater CVD Risks

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content